MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment
Spinal Cord Tumors
About this trial
This is an interventional diagnostic trial for Spinal Cord Tumors focused on measuring MRE, Slip Interface Imaging, Glioma, Magnetic Resonance Elastography, Spinal meningioma, Neurofibroma, Ependymoma, Astrocytoma, Glioblastoma, Spinal lipoma
Eligibility Criteria
Inclusion Criteria: All patients undergoing spinal cord tumor resection surgery are eligible for inclusion in the study cohort. Exclusion Criteria: Patients with metallic implants or foreign bodies in their bodies (pacemakers, artificial metallic heart valves, metal joints, metal implants, and those who cannot remove dentures, insulin pumps, or contraceptive rings) Pregnant women in the first trimester (within three months) Patients with severe claustrophobia or anxiety Patients with severe fever Patients who can not tolerate MRE Patients with vascular malformations and aneurysms. Patients who do not sign an informed consent
Sites / Locations
- Shengjing HospitalRecruiting
Arms of the Study
Arm 1
Experimental
Diagnostic(MRE, tumor grading of stiffness and adhesion)
Patients undergo a preoperative routine MRI scan and MRE the day before their scheduled surgery. During surgery, the tumor stiffness and adhesion are assessed and recorded by the surgeon according to established evaluation criteria. It is important to note that the surgeon does not have prior knowledge of the tumor's specific stiffness and adhesion before the surgery. This information is typically obtained through intraoperative assessment and observation.